| __timestamp | ADMA Biologics, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 9335772 |
| Thursday, January 1, 2015 | 6745968 | 12390000 |
| Friday, January 1, 2016 | 8494742 | 25602000 |
| Sunday, January 1, 2017 | 18092835 | 21262000 |
| Monday, January 1, 2018 | 22502922 | 28430000 |
| Tuesday, January 1, 2019 | 25910757 | 40849000 |
| Wednesday, January 1, 2020 | 35050817 | 60210000 |
| Friday, January 1, 2021 | 42896889 | 83664000 |
| Saturday, January 1, 2022 | 52458024 | 104097000 |
| Sunday, January 1, 2023 | 59020000 | 106916000 |
Unleashing the power of data
In the competitive landscape of biotechnology, managing operational costs is crucial for sustained growth. Over the past decade, from 2014 to 2023, ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses.
ADMA Biologics started with a modest $4.8 million in 2014, witnessing a steady increase to approximately $59 million by 2023. This represents a staggering 1,100% growth over the period. Meanwhile, Iovance Biotherapeutics began with $9.3 million in 2014, escalating to $107 million in 2023, marking an impressive 1,050% rise.
These figures highlight the aggressive expansion strategies of both companies, with Iovance consistently outspending ADMA. This trend underscores the dynamic nature of the biotech sector, where strategic investments in SG&A can drive innovation and market leadership.
Breaking Down SG&A Expenses: AstraZeneca PLC vs Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and ADMA Biologics, Inc.
SG&A Efficiency Analysis: Comparing Incyte Corporation and ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.: SG&A Expense Trends
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Galapagos NV
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.